Neuromyelitis Optica Spectrum Disorder as an Initial Presentation of Primary Sjogren's Syndrome

被引:52
作者
Kahlenberg, J. Michelle [1 ]
机构
[1] Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA
关键词
Sjogren's syndrome; myelitis; neuromyelitis optica; Devic's disease; NMO; aquaporin-4; ACUTE TRANSVERSE MYELOPATHY; NERVOUS-SYSTEM INVOLVEMENT; MYELITIS; MANIFESTATION; AQUAPORIN-4; PREDNISONE; THERAPY; DISEASE; CYCLOPHOSPHAMIDE; AUTOANTIBODIES;
D O I
10.1016/j.semarthrit.2010.05.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Longitudinal myelitis in patients with Sjogren's syndrome (SS) is a rarely reported occurrence. Here, we present a patient with longitudinal myelitis who was found to have both primary SS and a positive antibody to aquaporin-4 (NMO-IgG). We review the recent literature concerning the overlap between primary SS-associated myelitis and the presence of NMO-IgG, suggestive of a neuromyelitis optica spectrum disorder (NMOSD). Methods: A patient with longitudinal myelitis, SS, and a positive NMO-IgG is presented. A review of the relevant English literature based on a PubMed and Embase search is then discussed. The keywords used were Sjogren's syndrome, myelitis (longitudinal and transverse), neuromyelitis optica, and Devic's disease. Results: Our patient fulfills the criteria for both primary SS and NMOSD. Several small studies have shown that most SS patients with longitudinal myelitis are positive for the antibody to aquaporin-4. Additionally, minor salivary gland biopsies of patients with NMO or NMOSD have evidence of lymphocytic inflammation, suggesting that there may be an overlap in the mechanism of NMOSD and longitudinal myelitis secondary to primary SS. This overlap in mechanism may have important ramifications with regard to prognosis and treatment of SS-related myelitis. Conclusion: The presentation of longitudinal myelitis in a patient with SS should be considered a possible NMOSD. Checking for the presence antiaquaporin-4 antibodies provides important prognostic information and may help to guide treatment decisions. (C) 2011 Elsevier Inc. All rights reserved. Semin Arthritis Rheum 40:343-348
引用
收藏
页码:343 / 348
页数:6
相关论文
共 38 条
[1]   Rituximab Therapy in Primary Sjogren's Syndrome [J].
Alcantara, Cristina ;
Gomes, Maria Joao ;
Ferreira, Carlos .
CONTEMPORARY CHALLENGES IN AUTOIMMUNITY, 2009, 1173 :701-705
[2]  
Alhomoud IA, 2009, SAUDI MED J, V30, P1067
[3]   Transverse myelitis occurring in association with primary biliary cirrhosis and Sjogren's syndrome [J].
Anantharaju, A ;
Baluch, M ;
Van Thiel, DH .
DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (04) :830-833
[4]   Devic disease in a child with primary Sjogren syndrome [J].
Arabshahi, Bita ;
Pollock, Avrum N. ;
Sherry, David D. ;
Albert, Daniel A. ;
Kreiger, Portia A. ;
Pessler, Frank .
JOURNAL OF CHILD NEUROLOGY, 2006, 21 (04) :285-286
[5]   Primary Sjogren's syndrome mimicking neuromyelitis optica [J].
Barroso, Bruno .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2007, 18 (06) :507-507
[6]   Current concepts in the diagnosis of transverse myelopathies [J].
Brinar, Vesna V. ;
Habek, Mario ;
Zadro, Ivana ;
Barun, Barbara ;
Ozretic, David ;
Vranjes, Davorka .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2008, 110 (09) :919-927
[7]   Non-MS autoimmune demyelination [J].
Cikes, Nada ;
Bosnic, Dubravka ;
Sentic, Mirna .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2008, 110 (09) :905-912
[8]   An open label study of the effects of rituximab in neuromyelitis optica [J].
Cree, BAC ;
Lamb, S ;
Morgan, K ;
Chen, A ;
Waubant, E ;
Genain, C .
NEUROLOGY, 2005, 64 (07) :1270-1272
[9]   B cells in the pathophysiology of autoimmune neurological disorders: A credible therapeutic target [J].
Dalakas, Marinos C. .
PHARMACOLOGY & THERAPEUTICS, 2006, 112 (01) :57-70
[10]   Neurologic manifestations in primary Sjogren syndrome - A study of 82 patients [J].
Delalande, S ;
de Seze, J ;
Fauchais, AL ;
Hachulla, E ;
Stojkovic, T ;
Ferriby, D ;
Dubucquoi, S ;
Pruvo, JP ;
Vermersch, P ;
Hatron, PY .
MEDICINE, 2004, 83 (05) :280-291